Replies to post #242920 on Avid Bioservices Inc (CDMO)

[Couch]

Must be why Bavituximab is getting a little air play as of late via the scientific community.

http://www.targetedonc.com/publications/special-reports/2015/nsclc-issue9/immunotherapy-becoming-mainstay-of-nsclc-therapy

[jimsgtx]

Like I said Lem... Stick around for another year... Imho, buy now... Pphm will be a 4-6 billion company by then.